StreetAlpha.app
Home › Stocks › ACHV

Achieve Life Sciences, Inc. (ACHV)

Healthcare
$6.78
▲ +0.89%
LAST CLOSE · NOV 9

Achieve Life Sciences develops cytisinicline, a drug candidate intended to help people quit smoking or vaping. It last closed at $6.78 on Nov 9, up 0.89% on the day. The next earnings report for ACHV is expected around Tue, Mar 23, 2027. For the quarter ended Sep 2026, ACHV reported EPS of -$0.11. Over its last 8 reports the stock moved an average of 7.4% the session after earnings.

AI Auto Pilots
Is ACHV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ACHV.

Key Stats

Last 12 months
Results
Net income
−$111.7M
EPS (diluted)
−$1.41
Valuation
Market cap
$746.0M
110.0M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$59.7M
At Sep 30
Shareholder equity
$180.7M
Shares outstanding
110.0M
At Nov 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$33.2M−$33.2MFY2021FY2022: −$42.4M−$42.4MFY2022FY2023: −$29.8M−$29.8MFY2023FY2024: −$39.8M−$39.8MFY2024FY2025: −$54.6M−$54.6MFY2025

From ACHV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Mar 23
Estimated date · Time not announced
Reported EPS
-$0.11
Quarter ended Sep 2026
Year ago EPS
-$0.28
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.36Dec '24Mar 2025: -$0.37Mar '25Jun 2025: -$0.37Jun '25Sep 2025: -$0.28Sep '25Dec 2025: -$0.26Dec '25Mar 2026: -$0.19Mar '26Jun 2026: -$0.80Jun '26Sep 2026: -$0.11Sep '26Latest -$0.11
Revenue by quarter
Not enough quarters on file yet.
How ACHV moved after its last 8 reports
Average move the session after a report ±7.4%
Aug 11, 2026After the close−1.2%
May 12, 2026Time not announced+7.2%
Mar 24, 2026Time not announced−28.4%
Nov 6, 2025Time not announced−3.9%
Aug 7, 2025Time not announced0.0%
May 13, 2025Time not announced+6.8%
Mar 11, 2025Time not announced−4.6%
Nov 7, 2024After the close−7.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ACHVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ACHV
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ACHV

Technical Analysis

ACHV · as of the Nov 9 close · updated each morning
Pullback inside a longer uptrend

The stock sits between its 20 and 50 day averages. It is 16% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 48). The nearest support is the Pivot at $6.74, and the nearest resistance the Pivot R1 at $6.95.

Short trendBearish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityNormal, 6.4%/day
Key levels
$8.6452 week high+27.4%
$7.2850 day average+7.4%
$7.11Swing high (Jul 1)+4.9%
$6.95100 day average+2.5%
$6.95Pivot R1+2.5%
$6.78Last close
$6.74Pivot−0.6%
$6.7220 day average−0.9%
$6.56Pivot S1−3.2%
$6.33Swing low (Oct 22)−6.6%
$5.67200 day average−16.4%
$2.6252 week low−61.4%
Indicators
RSI (14)47.93Middle of its rangeNeutral
MACD-0.14Above its signal lineBullish
Stochastic36.0Middle of its rangeNeutral
ADX (14)17.9No clear trend
Williams %R-49.0Oversold below −80, overbought above −20Neutral
CCI (20)2.2Oversold below −100, overbought above 100Neutral
Rate of change+3.7%Change over 10 sessionsBullish
ATR (14)$0.43Typical daily range, 6.4% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Above
What happened before, for ACHV

What happened before

See how ACHV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ACHV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ACHV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2008.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ACHVHow many large options trades hit ACHV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ACHV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲78 buying vs 35 selling
  • ▲Held by funds +13.9 pts
  • ▲Funds holding +20
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding132112+17.9%
In funds' top 10220.0%
Held by funds89.0%75.1%+13.9 pts
New / increased33 / 4547 / 36−6.0%
Reduced / sold out22 / 1315 / 17+9.4%
Put/call ratio0.000.00−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ACHV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACHV is in one of them and how their past ACHV trades turned out.

ACHV in the AI portfolios
Loading…

ACHV News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ACHV in an article yet. Here's the latest on the wider market.

ACHV in the news

About Achieve Life Sciences

Achieve Life Sciences is a specialty pharmaceutical company based in Seattle, Washington. It is developing cytisinicline, a drug candidate for treating nicotine dependence in people who want to quit smoking or vaping. The drug has not yet been approved by U.S. regulators. Its target customers are adult smokers and vapers, and the company also holds rights to commercialize the drug in regions outside a European partner's territory.

Headquarters
Seattle, WA